Cure Parkinson’s
20 results.
The Cure Parkinson's Trust (CPT) is delighted to announce the publication of the results of a Phase II clinical trial evaluating ambroxol as a…
This story originally appeared on The Cure Parkinson’s Trust website. To learn more, click here.
It was announced today that the Australian Parkinson's…
Did you miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? Don’t worry. We have you covered.
Just over a week ago, the…
Grand Rapids, Mich. (Sept. 25, 2017)—Leading Parkinson’s experts and advocates from around the world will gather at Van Andel Research Institute in…
In less than a month, scientists, physicians and people with Parkinson’s will gather at Van Andel Research Institute with one goal in mind—finding a cure…
Evidence continues to mount that a newer class of anti-diabetic drugs called incretin mimetics, or glucagon-like peptide-1 receptor agonists, could slow…
When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel…
GRAND RAPIDS, Mich. (Dec. 7, 2016)—A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of…